Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus

Nitazoxanide is a broad-spectrum antiviral agent undergoing clinical development for treatment of influenza and other viral respiratory infections. Nitazoxanide exhibits in vitro activity against Middle East respiratory syndrome coronavirus (MERS-CoV) and other coronaviruses, inhibiting expression o...

Descripción completa

Detalles Bibliográficos
Autor principal: Rossignol, Jean-François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: King Saud Bin Abdulaziz University for Health Sciences. Production and hosting by Elsevier Limited. 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102735/
https://www.ncbi.nlm.nih.gov/pubmed/27095301
http://dx.doi.org/10.1016/j.jiph.2016.04.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102735/
https://www.ncbi.nlm.nih.gov/pubmed/27095301
http://dx.doi.org/10.1016/j.jiph.2016.04.001

Ejemplares similares